This compound is primarily utilized in the pharmaceutical industry as an active pharmaceutical ingredient (API). It is commonly employed in the development of medications targeting central nervous system (CNS) disorders. Specifically, it acts as a selective serotonin reuptake inhibitor (SSRI), making it effective in the treatment of conditions such as depression, anxiety, and certain mood disorders. Its mechanism of action involves enhancing serotonin levels in the brain, which helps regulate mood and emotional stability. Additionally, the compound's unique structure allows for improved bioavailability and reduced side effects compared to some traditional SSRIs. It is often formulated into oral tablets or capsules for convenient patient administration. Ongoing research is also exploring its potential in addressing other neurological conditions, such as obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD).